🇺🇸 FDA
Pipeline program

IkT-001Pro, Placebo to match 100 mg IKT-001 tablets

IKT-001-201

Phase 3 small_molecule active

Quick answer

IkT-001Pro, Placebo to match 100 mg IKT-001 tablets for Pulmonary Arterial Hypertension is a Phase 3 program (small_molecule) at Inhibikase Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Inhibikase Therapeutics
Indication
Pulmonary Arterial Hypertension
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials